- Home
- ABVX vs GATX Comparison
ABVX vs GATX Comparison
Compare ABVX & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- GATX
- Stock Information
- Founded
- ABVX 2013
- GATX 1898
- Country
- ABVX France
- GATX United States
- Employees
- ABVX N/A
- GATX N/A
- Industry
- ABVX
- GATX Transportation Services
- Sector
- ABVX
- GATX Consumer Discretionary
- Exchange
- ABVX Nasdaq
- GATX Nasdaq
- Market Cap
- ABVX 5.3B
- GATX 5.5B
- IPO Year
- ABVX N/A
- GATX N/A
- Fundamental
- Price
- ABVX $70.44
- GATX $156.45
- Analyst Decision
- ABVX Buy
- GATX Buy
- Analyst Count
- ABVX 7
- GATX 2
- Target Price
- ABVX $74.86
- GATX $172.50
- AVG Volume (30 Days)
- ABVX 3.2M
- GATX 180.8K
- Earning Date
- ABVX 08-11-2025
- GATX 07-29-2025
- Dividend Yield
- ABVX N/A
- GATX 1.56%
- EPS Growth
- ABVX N/A
- GATX 34.45
- EPS
- ABVX N/A
- GATX 8.74
- Revenue
- ABVX $11,444,012.00
- GATX $1,671,000,000.00
- Revenue This Year
- ABVX N/A
- GATX $10.94
- Revenue Next Year
- ABVX $41.36
- GATX $5.40
- P/E Ratio
- ABVX N/A
- GATX $17.90
- Revenue Growth
- ABVX 128.98
- GATX 11.74
- 52 Week Low
- ABVX $4.77
- GATX $127.70
- 52 Week High
- ABVX $75.51
- GATX $168.89
- Technical
- Relative Strength Index (RSI)
- ABVX 80.00
- GATX 54.94
- Support Level
- ABVX $68.26
- GATX $154.87
- Resistance Level
- ABVX $73.90
- GATX $161.24
- Average True Range (ATR)
- ABVX 3.64
- GATX 3.16
- MACD
- ABVX -1.64
- GATX 0.69
- Stochastic Oscillator
- ABVX 46.06
- GATX 63.23
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.